Louis W. Sullivan

Board Member · UNITED THERAPEUTICS Corp

Rank #18,811 SEC EDGAR (United States) ↗

Details

Member of the boardPharmaceuticals & BiotechnologyUTHRSEC CIK 0001193522

Computed from SEC EDGAR filings and closing prices — not copied from any wealth ranking. Dataset . How we calculate this.

Disclosed holdings
$2.4M
1-day change
▼ 0.46%
Positions on file
2
issuers disclosed in Forms 3/4/5 and Schedules 13D/G

Disclosed holdings over time 53 weekly points

What the 2 currently disclosed positions would have been worth at each week’s closing price. A rising line means the shares got more valuable, not that this person bought more.

How the line is built

Share counts are as last reported to the SEC and held constant; only prices move.

2025-09-05$2.2M – $3.4M2026-09-04

Insider activity May 3, 2024 – Dec 22, 2025

Louis W. Sullivan is recorded in filings to the U.S. SEC via EDGAR as member of the board, and reported 36 transactions between May 3, 2024 and Dec 22, 2025. The buy and sell totals below count only codes P, S.

Why the other codes are excluded

Share awards (A), shares withheld to pay tax (F), option exercises (M) and gifts (G) also appear in the table, but they are consequences of a pay package or a private transfer, not a decision to buy or sell on the open market. Counting them would turn this into a compensation ranking.

Open-market buys (code P)
None
0 purchases on file
Open-market sales (code S)
$14.16M
28 sales on file priced rows only
All reported transactions
36
every code, including awards and exercises
Pattern
Net seller in the final 12 months of the window
last 12 months of the window

Reported transactions

Price 0.00 is a real reported figure on gifts (G) and share awards (A) — not a missing number. The 25 most recent rows are grouped into 8 lines by date, company and transaction type — open a line to see every lot with its own source link. We hold 37 on file in total. See the full history on EDGAR ↗

How to read this list

Every row is one line of one Form 4 or Form 5, with the filing it came from. Where the record carries no price at all we leave the cell empty instead of guessing one.

The shares and money on a grouped line add up only the lots listed inside that line, and only when every one of them carries the figure. Where a group mixes more than one reporting currency we leave the money blank rather than convert — no source publishes the rate that conversion would need.

  1. UNITED THERAPEUTICS Corp UTHR M Option exercise or conversionnot a buy/sell decisionreported at zero 650 shares $0 at $0.00 SEC filing ↗
  2. UNITED THERAPEUTICS Corp UTHR M Option exercise or conversion × 2not a buy/sell decision 5,950 shares $1.22M
    The 2 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    3,230 $183.98 $594.3K SEC filing ↗
    2,720 $229.81 $625.1K SEC filing ↗
  3. UNITED THERAPEUTICS Corp UTHR S Open-market sale × 2 5,950 shares $3.05M
    The 2 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    1,087 $511.22 $555.7K SEC filing ↗
    4,863 $512.34 $2.49M SEC filing ↗
  4. UNITED THERAPEUTICS Corp UTHR M Option exercise or conversionnot a buy/sell decisionreported at zero 590 shares $0 at $0.00 SEC filing ↗
  5. Emergent BioSolutions Inc. EBS A Grant or awardnot a buy/sell decisionreported at zero 34,403 shares $0 at $0.00 SEC filing ↗
  6. UNITED THERAPEUTICS Corp UTHR G Bona fide giftnot a buy/sell decisionreported at zero 1,851 shares $0 at $0.00 SEC filing ↗
  7. UNITED THERAPEUTICS Corp UTHR S Open-market sale × 16 19,211 shares $7.16M
    The 16 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    1,525 $373.06 $568.9K SEC filing ↗
    100 $370.78 $37.1K SEC filing ↗
    1,962 $374.17 $734.1K SEC filing ↗
    2,700 $375.03 $1.01M SEC filing ↗
    400 $377.46 $151.0K SEC filing ↗
    944 $379.67 $358.4K SEC filing ↗
    800 $381.37 $305.1K SEC filing ↗
    100 $382.25 $38.2K SEC filing ↗
    1,121 $366.11 $410.4K SEC filing ↗
    600 $366.97 $220.2K SEC filing ↗
    1,307 $368.50 $481.6K SEC filing ↗
    2,100 $369.32 $775.6K SEC filing ↗
    1,400 $370.30 $518.4K SEC filing ↗
    1,501 $373.12 $560.1K SEC filing ↗
    200 $371.25 $74.3K SEC filing ↗
    2,451 $374.14 $917.0K SEC filing ↗
  8. UNITED THERAPEUTICS Corp UTHR M Option exercise or conversionnot a buy/sell decision 15,000 shares $2.63M at $175.43 SEC filing ↗

Disclosed holdings

Shares is the amount on the form; value is that amount times the closing price shown. Rows with no closing price are left blank, so they may add up to less than the headline figure.

What is not counted here

Each row is one filing you can open. Private companies, real estate, bonds and crypto are not in SEC insider filings and are therefore not counted here.

Equity positions disclosed to the SEC, with the source filing behind each row.
Issuer Ticker Security Shares Close Value Form Reported Filing
UNITED THERAPEUTICS Corp UTHR Common Stock 3,200 $487.61 $1.6M 4 EDGAR ↗
Emergent BioSolutions Inc. EBS Common Stock 139,098 $6.21 $863.8K 4 EDGAR ↗

Other insiders at the same companies

People who also file with the SEC at a company where Louis W. Sullivan reports shares.

Sharing a filing does not mean they work together day to day — it means both names appear on the same issuer’s insider record.

Sources

The filings linked in the tables above are the sources for every figure on this page.

Think a number here is wrong? Open the linked filing and compare — how to report it.

Profile record last refreshed Sep 8, 2026.